📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Satiogen

1.1 - Company Overview

Satiogen Logo

Satiogen

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of specialty pharmaceutical therapies targeting type 2 diabetes, offering metabolic mechanism therapy designed to regulate nutrient intake and postprandial glucose. Products include a substitute for metformin in gliptin formulations and an OTC nutraceutical.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Satiogen

Home Diagnostics Logo

Home Diagnostics

HQ: United States Website
  • Description: Provider of blood glucose monitoring systems and disposable supplies for diabetics, developed, manufactured and marketed by Home Diagnostics, offering performance and features comparable to or better than competitors' products, in most cases at a substantially lower price.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Home Diagnostics company profile →
Animas Logo

Animas

HQ: United States Website
  • Description: Provider of external insulin pumps for people with diabetes, designing, developing, manufacturing, and selling these devices. Believed to be the second-largest supplier in the U.S. by new pump placements. Introduced the R1000 in July 2000 and expects to begin shipping its third-generation pump.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Animas company profile →
Fractyl Health Logo

Fractyl Health

HQ: United States Website
  • Description: Provider of curative therapies for metabolic diseases, including Revita, a therapy designed to modify duodenal dysfunction via hydrothermal ablation to restore metabolic health, and Rejuva, a preclinical AAV gene therapy platform aimed at improving islet function for long-term remission of T2D and obesity.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Fractyl Health company profile →
TheracosBio Logo

TheracosBio

HQ: United States Website
  • Description: Provider of Brenzavvy, an FDA-approved oral treatment for type 2 diabetes, with a focus on accessible medications.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full TheracosBio company profile →
Glycostasis Logo

Glycostasis

HQ: United States Website
  • Description: Provider of engineered human protein technology that releases insulin when blood glucose levels rise and binds it when levels fall, mimicking the natural regulation of insulin in healthy individuals.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Glycostasis company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Satiogen

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Satiogen

2.2 - Growth funds investing in similar companies to Satiogen

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Satiogen

4.2 - Public trading comparable groups for Satiogen

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Satiogen

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Satiogen

What does Satiogen do?

Satiogen is a provider of specialty pharmaceutical therapies targeting type 2 diabetes, offering metabolic mechanism therapy designed to regulate nutrient intake and postprandial glucose. Products include a substitute for metformin in gliptin formulations and an OTC nutraceutical.

Who are Satiogen's competitors?

Satiogen's competitors and similar companies include Home Diagnostics, Animas, Fractyl Health, TheracosBio, and Glycostasis.

Where is Satiogen headquartered?

Satiogen is headquartered in United States.

How many employees does Satiogen have?

Satiogen has 1,000 employees 🔒.

When was Satiogen founded?

Satiogen was founded in 2010 🔒.

What sector and industry vertical is Satiogen in?

Satiogen is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Satiogen

Who are the top strategic acquirers in Satiogen's sector and industry

Top strategic M&A buyers and acquirers in Satiogen's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Satiogen?

Top strategic M&A buyers groups and sectors for Satiogen include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Satiogen's sector and industry vertical

Which are the top PE firms investing in Satiogen's sector and industry vertical?

Top PE firms investing in Satiogen's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Satiogen's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Satiogen's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Satiogen's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Satiogen include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Satiogen's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Satiogen?

The key public trading comparables and valuation benchmarks for Satiogen include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Satiogen for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Satiogen with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Satiogen's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Satiogen with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Satiogen's' sector and industry vertical?

Access recent funding rounds and capital raises in Satiogen's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Satiogen